Towards an Improvement in Diagnosis and Genetic Counselling in Syndromic Poikiloderma
概览
- 阶段
- 不适用
- 干预措施
- High-throughput exome sequencing
- 疾病 / 适应症
- Poikiloderma
- 发起方
- Centre Hospitalier Universitaire Dijon
- 入组人数
- 39
- 试验地点
- 1
- 主要终点
- Identification of novel genes involved in syndromic poikiloderma
- 状态
- 已完成
- 最后更新
- 上个月
概览
简要总结
In the context of this study, the investigators wish to take advantage of high-throughput genetic techniques (microarray and high-throughput exome sequencing) to identify new genes implicated in syndromic poikiloderma so as to improve the diagnostic decision tree in these syndromes, opportunities for genetic counselling for patients and their families and the follow-up of patients, notably with regard to the risk of tumours.
This study will make it possible to identify new genes implicated in syndromic poikiloderma and improve the diagnostic strategy proposed to patients with these syndromes, and to propose to patients a confirmed diagnosis, appropriate follow-up, notably with regard to the risk of tumours, genetic counselling to families and eventually an antenatal diagnosis to couples who would like to have one for future pregnancies.
The identification of new genetic causes of syndromic poikiloderma will also make it possible to complete the current classification of these syndromes
研究者
入排标准
入选标准
- •patients with syndromic poikiloderma, defined by the association of poikiloderma with other extradermatological clinical signs,
- •normal array-CGH, screening for chromosomal rearrangements,
- •absence of mutations in the genes RECQL4, KIND1 or C16orf57,
- •sporadic or familial involvement.
排除标准
- 未提供
研究组 & 干预措施
patients with poikiloderma
干预措施: High-throughput exome sequencing
结局指标
主要结局
Identification of novel genes involved in syndromic poikiloderma
时间窗: day 1